why choose us

First received: June 20, 2023

Clinical Trial: Effect of Novel Antidiabetic Drug Combined With Angiotensin Receptor/Neprilysin Inhibitor on Urinary Protein

Study Status: Completed

Recruit Status: RECRUITING

Condition: Type 2 Diabetes

Study Type: OBSERVATIONAL


Official Title: the Effect of Novel Antidiabetic Drug Combined With Angiotensin Receptor/Neprilysin Inhibitor Over Monotherapy on Urinary Protein in Patients With Type 2 Diabetes

Brief Summary: The purpose of this study is to determine whether the combination of SGLT2i and ARNI in type 2 diabetic patients with combined albuminuria could reduce urinary protein more significantly than single agent.

Read more